Live Breaking News & Updates on Al Guillem|Page 1

Stay updated with breaking news from Al guillem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Renibus Therapeutics Raises $35M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Frank Stonebanks , Al Guillem , Renibus Therapeutics , Executive Chairman ,

BioSpace Movers & Shakers, Feb. 18

With new members of leadership teams and boards of directors, these biopharma and life sciences companies are plotting the course for a strong 2022. ....

United States , Israel General , Third Point , France General , Hebrew University , Chas Bountra , Steven Bernstein , Rebecca Legare , Susan Abu Absi , Eli Lilly , Schond Greenway , Aaron Galaznik , Gerardp Griffin , Mike Cola , Kristen Harrington Smith , Andrea Teague , Paul Reider , Raphael Mechoulam , Frank Stonebanks , Bristol Myers Squibb , Jim Mellon , Rachelw Humphrey , Ravi Raval , Amy Locke , Robert Mcrae , Chris Sullivan ,

BioSpace Movers & Shakers, Feb. 18

BioSpace Movers & Shakers, Feb. 18 - read this article along with other careers information, tips and advice on BioSpace ....

United States , Israel General , Third Point , France General , Hebrew University , Chas Bountra , Steven Bernstein , Rebecca Legare , Susan Abu Absi , Eli Lilly , Schond Greenway , Aaron Galaznik , Gerardp Griffin , Mike Cola , Kristen Harrington Smith , Andrea Teague , Paul Reider , Raphael Mechoulam , Frank Stonebanks , Bristol Myers Squibb , Jim Mellon , Rachelw Humphrey , Ravi Raval , Amy Locke , Robert Mcrae , Chris Sullivan ,

Nanoscope Therapeutics Receives Orphan Drug Designation for gene therapy of blindness

Nanoscope Therapeutics Receives Orphan Drug Designation for gene therapy of blindness
This is the second program based on Nanoscope s Multi-Characteristic Opsin Platform to receive orphan designation. This designation highlights the unmet need for therapy of patients with rare form of inherited macular degeneration.
News provided by
Share this article
Share this article
BEDFORD, Texas, Jan. 25, 2021 /PRNewswire/ NANOSCOPE THERAPEUTICS Inc., a clinical-stage biotechnology company determined to change lives through the ocular gene therapy, today announced that it has received an Orphan drug designation from FDA for gene therapy-based treatment of Stargardt disease, a form of inherited retinal degenerative disease caused by gene mutation and passed on to children. ....

United States , Psulagna Bhattacharya , Samarendra Mohanty , Al Guillem , Federation For Fighting Blindness , Corporate Communications , Fighting Blindness , Chief Executive Officer , Multi Characteristic Opsin , Retinitis Pigmentosa , Nanoscope Therapeutics , Chief Medical Officer , Orphan Drug Act , Chief Scientific , ஒன்றுபட்டது மாநிலங்களில் , சுழஞ்நா பட்டாச்சார்யா , சமரேந்திற மொஹாண்தி , கூட்டமைப்பு க்கு சண்டை குருட்டுத்தன்மை , பெருநிறுவன தகவல்தொடர்புகள் , சண்டை குருட்டுத்தன்மை , தலைமை நிர்வாகி அதிகாரி , தலைமை மருத்துவ அதிகாரி , ஆர்ஃபந் மருந்து நாடகம் , தலைமை அறிவியல் ,